Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Symbio Pharmaceuticals Limited (4582) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Brincidofovir, CidofovirAdenovirus InfectionsPhase IIIRecruitingA Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCTJan 20, 2026―
BrincidofovirRelapsed Or Refractory Lymphoma Including Enklphase1AndPhase2SuspendedA Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaDec 24, 2024
BrincidofovirKidney Transplantation, Nephropathy, Bk Virus InfectionPhase IITerminatedStudy to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney TransplantationAug 16, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Symbio Pharmaceuticals Limited (JP:4582) have in its pipeline
Symbio Pharmaceuticals Limited JP:4582 is currently developing the following drugs: Brincidofovir, Cidofovir, Brincidofovir. These drug candidates are in various stages of clinical development as the company works toward FDA approval.